Status:
UNKNOWN
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
Lead Sponsor:
All Natural Medicine Clinic, LLC
Conditions:
Sequelae of; Infection
Post Infection Glomerulonephritis
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the vir...
Detailed Description
SARS-CoV-2 caused sequela is a pathological condition, and specific cells are damaged from a prior disease, injury, or attack. Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) is caused by an infect...
Eligibility Criteria
Inclusion
- The participants must receive medical herbs as a treatment method;
- Participants are not limited by age, sex, race, or location;
- Participants are including infants;
- Participants are including pregnant woman;
- The participants had an infection history of SARS-CoV-2 in past one month;
- The participants provide SARS-CoV-s diagnoses (Molecular or Antigen). Test was \*positive, now hold negative reports
- Participants hold reports of immune system medics, like immunoglobulin M (IgM), immunoglobulin G (IgG);
- Reports that is evidence of specific organ damaged, including assay reports or image reports
- Participants must agree to take medical herbs for at least 3 months as one course continually;
- Participants must agree to repeat the assay and image test to monitor the treatment results;
- Participants must report their Manifestations clearly to investigators;
- Participants must agree to continue the next course of the treatment after the evaluation if it is necessary;
- The treatment goal is to become symptom-free, and experiment assays went to normal
Exclusion
- Participants don't want to take medical herbs;
- Participants have symptoms of sequelae but is not caused by SARS-CoV-2 (COVID-19);
- Participants have not symptoms after COVID-19 infection, no assays abnormal either;
- Participants don't want to repeat the experiment assays;
- Participants are in E.R. or ICU during the application or enrollment;
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04846010
Start Date
March 1 2021
End Date
October 1 2022
Last Update
May 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All Natural Medicine Clinic, LLC
Rockville, Maryland, United States, 20852-2235